Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EKF Diagnostics HoldingsLSE:EKF -0.40%51 Buyback Yield % is 4.61 as of Jul. 19, 2026, which is 46000% above its 10-year median of 0.01. GuruFocus rates LSE:EKF with a GF Score™ of 51/100 and a GF Value™ of £0.28 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 348 Medical Devices & Instruments companies, EKF Diagnostics Holdings ranks better than 95.4% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LSE:EKF vs ABT, SYK, MDT: Buyback Yield % Comparison
For the Medical Devices subindustry, EKF Diagnostics Holdings's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EKF Diagnostics Holdings Buyback Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, EKF Diagnostics Holdings's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where EKF Diagnostics Holdings's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EKF Diagnostics Holdings (LSE:EKF) has a Buyback Yield % of 4.61 as of Jul. 19, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on EKF Diagnostics Holdings and its competitors. This is 46000% above median its historical median of 0.01. According to the industry distribution chart, EKF Diagnostics Holdings ranks #16 out of 348 companies in the Medical Devices & Instruments industry, placing it in the top 4.6%.
Is EKF Diagnostics Holdings' Buyback Yield % too high?
EKF Diagnostics Holdings' current Buyback Yield % of 4.61 is 46000% above median its 10-year median of 0.01. Based on the distribution chart, EKF Diagnostics Holdings ranks #16 out of 348 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, EKF Diagnostics Holdings has a GF Score™ of 51/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does EKF Diagnostics Holdings' Buyback Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, EKF Diagnostics Holdings ranks #16 out of 348 companies for Buyback Yield %. This places EKF Diagnostics Holdings in the top 5% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Medical Devices & Instruments company?
A good Buyback Yield % depends on the Medical Devices & Instruments industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on EKF Diagnostics Holdings and its competitors. EKF Diagnostics Holdings's current Buyback Yield % is 4.61, which is 46000% above median its own 10-year median of 0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EKF Diagnostics Holdings stock overvalued right now?
Based on GuruFocus' analysis, EKF Diagnostics Holdings (LSE:EKF) is currently considered Modestly Undervalued. The stock's GF Value™ is £0.28, compared to a current price of £0.25 — trading 10% below its estimated fair value. The current Buyback Yield % is 4.61, which is 46000% above median its 10-year median of 0.01. EKF Diagnostics Holdings' overall GF Score™ is 51/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For EKF Diagnostics Holdings (LSE:EKF), the current Buyback Yield % is 4.61 as of Jul. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is EKF Diagnostics Holdings (LSE:EKF) Overvalued in 2026?
Based on GuruFocus' analysis, EKF Diagnostics Holdings stock appears to be undervalued.
The current stock price of £0.25 is trading 10% below its estimated GF Value™ of £0.28.
GuruFocus considers EKF Diagnostics Holdings to be Modestly Undervalued.
Key valuation signals for LSE:EKF:
Buyback Yield %: 4.61 (46000% above median its 10-year median of 0.01)
GF Value™: £0.28 vs. price of £0.25 (10% below fair value)
No single metric tells the full story. See the LSE:EKF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
EKF Diagnostics Holdings PLC is engaged in development, manufacture and supply of products and services into the in-vitro diagnostic (IVD) market place. The Group has presence in the UK, USA, Germany, and Russia, and sells throughout the world including Europe, the Middle East, the Americas, Asia, and Africa. It derive their revenue from the manufacture and sale of medical diagnostic equipment and reagents. Other services include the servicing and distribution of third party company products under separate distribution agreements.
51GF Score
Get the complete analysis for LSE:EKF
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:EKF has been successfully added to your 
